相似文献
1
Editorial: Antibody-mediated rejection.
Front Transplant. 2024 Apr 10;3:1408225. doi: 10.3389/frtra.2024.1408225. eCollection 2024.
2
Antibody-Mediated Rejection in Solid Organ Transplant.
AACN Adv Crit Care. 2016 Jul;27(3):316-323. doi: 10.4037/aacnacc2016366.
3
Humoral immunity and antibody-mediated rejection in solid organ transplantation.
Semin Immunol. 2011 Aug;23(4):224-34. doi: 10.1016/j.smim.2011.08.021. Epub 2011 Sep 29.
4
Long-term results of ABO-incompatible living kidney transplantation: a single-center experience.
Transplantation. 1998 Jan 27;65(2):224-8. doi: 10.1097/00007890-199801270-00014.
5
Bone marrow augmentation in kidney transplantation: a large animal study.
Transpl Int. 2001 Jun;14(3):159-69. doi: 10.1007/s001470100318.
6
Editorial: T-Cell and Antibody-Mediated Rejection After Organ Transplantation in the Post-COVID-19 Era - Diagnosis, Immunological Risk Evaluation and Therapy.
Front Immunol. 2022 Jul 5;13:968668. doi: 10.3389/fimmu.2022.968668. eCollection 2022.
7
The role of B cell immunity in VCA graft rejection and acceptance.
Hum Immunol. 2019 Jun;80(6):385-392. doi: 10.1016/j.humimm.2019.03.002. Epub 2019 Mar 2.
8
Issues in solid-organ transplantation in children: translational research from bench to bedside.
Clinics (Sao Paulo). 2014;69 Suppl 1(Suppl 1):55-72. doi: 10.6061/clinics/2014(sup01)11.
9
Variable Benefits of Antibody Induction by Kidney Allograft Type.
J Surg Res. 2020 Apr;248:69-81. doi: 10.1016/j.jss.2019.11.015. Epub 2019 Dec 19.
10
Outstanding questions in transplantation: B cells, alloantibodies, and humoral rejection.
Am J Transplant. 2019 Aug;19(8):2155-2163. doi: 10.1111/ajt.15323. Epub 2019 Apr 10.
本文引用的文献
1
Restrictive allograft syndrome vs bronchiolitis obliterans syndrome: Immunological and molecular characterization of circulating exosomes.
J Heart Lung Transplant. 2022 Jan;41(1):24-33. doi: 10.1016/j.healun.2021.09.001. Epub 2021 Sep 10.
2
Circulating exosomes with lung self-antigens as a biomarker for chronic lung allograft dysfunction: A retrospective analysis.
J Heart Lung Transplant. 2020 Nov;39(11):1210-1219. doi: 10.1016/j.healun.2020.07.001. Epub 2020 Jul 7.
3
Antibodies against Angiotensin II Type 1 and Endothelin A Receptors: Relevance and pathogenicity.
Hum Immunol. 2019 Aug;80(8):561-567. doi: 10.1016/j.humimm.2019.04.012. Epub 2019 Apr 19.
4
The impact of non-HLA antibodies on outcomes after lung transplantation and implications for therapeutic approaches.
Hum Immunol. 2019 Aug;80(8):583-587. doi: 10.1016/j.humimm.2019.04.008. Epub 2019 Apr 17.
5
Association between Allosensitization and Waiting List Outcomes among Adult Lung Transplant Candidates in the United States.
Ann Am Thorac Soc. 2019 Jul;16(7):846-852. doi: 10.1513/AnnalsATS.201810-713OC.
6
Human leukocyte antigens antibodies after lung transplantation: Primary results of the HALT study.
Am J Transplant. 2018 Sep;18(9):2285-2294. doi: 10.1111/ajt.14893. Epub 2018 May 15.
Zotero 插件